Physician profile
John C Kim
NPI 1073554648
$32,714.38
in general payments reported to CMS, 2019-2025
17 companies · $28.75 in 2025
The $28.75 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2021: $848 · 2022: $24K · 2023: $8,059 · 2024: $18.40 · 2025: $28.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,820 · Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,820.00 |
| Food and Beverage | $286.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $31,280.00 | 2022-2023 | |
| Intuitive Surgical, INC. | $778.98 | 2021 | |
| Abbvie INC. | $240.34 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $70.70 | 2023 | Myfembree |
| Exeltis, USA INC. | $46.00 | 2022-2023 | Slynd |
| Sage Therapeutics, LLC | $37.11 | 2022 | |
| Myovant Sciences INC. | $36.62 | 2021 | |
| Therapeuticsmd, INC. | $35.80 | 2022 | |
| Agile Therapeutics, INC. | $35.38 | 2022-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $28.75 | 2025 | |
| Mayne Pharma Commercial LLC | $24.48 | 2023 | |
| Astellas Pharma US INC | $22.30 | 2023 | Veozah |
| Organon LLC | $19.69 | 2021 | |
| Gynesonics, INC. | $18.40 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Meditrina | $14.76 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $12.77 | 2021 | |
| Avion Pharmaceuticals | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.